These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14537120)

  • 41. Local detection of prostate cancer by positron emission tomography with 2-fluorodeoxyglucose: comparison of filtered back projection and iterative reconstruction with segmented attenuation correction.
    Turlakow A; Larson SM; Coakley F; Akhurst T; Gonen M; Macapinlac HA; Kelly W; Leibel S; Humm J; Scardino P; Scher H; Hricak H
    Q J Nucl Med; 2001 Sep; 45(3):235-44. PubMed ID: 11788816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative assessment of 18F-FDG PET in patients with Hodgkin lymphoma: is it significantly affected by contrast-enhanced computed tomography attenuation correction?
    Voltin CA; Mettler J; Boellaard R; Kuhnert G; Dietlein M; Borchmann P; Drzezga A; Kobe C
    Nucl Med Commun; 2019 Mar; 40(3):249-257. PubMed ID: 30461699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of uptake of 2-deoxy-2-[18F] fluoro-D-glucose by fungal-associated inflammation: the standardized uptake value is greater for lesions of blastomycosis than for lymphoma in dogs with naturally occurring disease.
    Bassett CL; Daniel GB; Legendre AM; Bochsler PN; Smith GT
    Mol Imaging Biol; 2002 May; 4(3):201-7. PubMed ID: 14537124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans.
    Kanstrup IL; Klausen TL; Bojsen-Møller J; Magnusson P; Zerahn B
    Clin Physiol Funct Imaging; 2009 Apr; 29(2):108-13. PubMed ID: 19076727
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer.
    van Westreenen HL; Cobben DC; Jager PL; van Dullemen HM; Wesseling J; Elsinga PH; Plukker JT
    J Nucl Med; 2005 Mar; 46(3):400-4. PubMed ID: 15750150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correction of quantification errors in pelvic and spinal lesions caused by ignoring higher photon attenuation of bone in [18F]NaF PET/MR.
    Schramm G; Maus J; Hofheinz F; Petr J; Lougovski A; Beuthien-Baumann B; Oehme L; Platzek I; van den Hoff J
    Med Phys; 2015 Nov; 42(11):6468-76. PubMed ID: 26520736
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
    Cohade C; Osman M; Pannu HK; Wahl RL
    J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma.
    Hoffmann M; Vogelsang H; Kletter K; Zettinig G; Chott A; Raderer M
    Gut; 2003 Mar; 52(3):347-51. PubMed ID: 12584214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Fundamental evaluation of segmented attenuation correction method for clinical FDG-PET studies: simulation of pulmonary mass lesions in phantom studies].
    Matsumoto K; Mori H
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2002 Dec; 58(12):1579-85. PubMed ID: 12577016
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A weight index for the standardized uptake value in 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography.
    Thie JA; Hubner KF; Isidoro FP; Smith GT
    Mol Imaging Biol; 2007; 9(2):91-8. PubMed ID: 17205367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative analysis of MRI-guided attenuation correction techniques in time-of-flight brain PET/MRI.
    Mehranian A; Arabi H; Zaidi H
    Neuroimage; 2016 Apr; 130():123-133. PubMed ID: 26853602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Test-Retest Variability in Lesion SUV and Lesion SUR in
    Hofheinz F; Apostolova I; Oehme L; Kotzerke J; van den Hoff J
    J Nucl Med; 2017 Nov; 58(11):1770-1775. PubMed ID: 28473598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Standardized Uptake Values from PET/MRI in Metastatic Breast Cancer: An Organ-based Comparison With PET/CT.
    Pujara AC; Raad RA; Ponzo F; Wassong C; Babb JS; Moy L; Melsaether AN
    Breast J; 2016 May; 22(3):264-73. PubMed ID: 26843433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of corrections for blood glucose and body size on [18F]FDG PET standardised uptake values in lung cancer.
    Hallett WA; Marsden PK; Cronin BF; O'Doherty MJ
    Eur J Nucl Med; 2001 Jul; 28(7):919-22. PubMed ID: 11504091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study.
    Niccoli Asabella A; Ciccone MM; Cortese F; Scicchitano P; Gesualdo M; Zito A; Di Palo A; Angiletta D; Regina G; Marzullo A; Rubini G
    Ann Nucl Med; 2014 Jul; 28(6):571-9. PubMed ID: 24737136
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of liver SUV using unenhanced CT versus contrast-enhanced CT for attenuation correction in (18)F-FDG PET/CT.
    ter Voert EE; van Laarhoven HW; Kok PJ; Oyen WJ; Visser EP; de Geus-Oei LF
    Nucl Med Commun; 2014 May; 35(5):472-7. PubMed ID: 24509519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of Positron Emission Tomography Using 2-[18F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[18F]-fluorothymidine in Lung Cancer Imaging.
    Wang FL; Tan YY; Gu XM; Li TR; Lu GM; Liu G; Huo TL
    Chin Med J (Engl); 2016 Dec; 129(24):2926-2935. PubMed ID: 27958224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dual time point 2-[18F]fluoro-2'-deoxyglucose positron emission tomography in chronic bacterial osteomyelitis.
    Sahlmann CO; Siefker U; Lehmann K; Meller J
    Nucl Med Commun; 2004 Aug; 25(8):819-23. PubMed ID: 15266177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT.
    Heusch P; Buchbender C; Köhler J; Nensa F; Gauler T; Gomez B; Reis H; Stamatis G; Kühl H; Hartung V; Heusner TA
    J Nucl Med; 2014 Mar; 55(3):373-8. PubMed ID: 24504054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.